January 13, 2021 Town Hall Member Meeting

January 13, 2021 Annual Town Hall Member Meeting 

You’re invited to join the Clinical TMS Society for the January 13, 2021 Annual Town Hall Member Meeting. 

Presentation Overview: 

Join the Clinical TMS Society President, Kimberly Cress, MD, President-Elect, Randy Pardell, MD, and our current committee co-chairs for an update on all 2020-2021 committee projects.

This is your opportunity to learn more about the various goals and projects, ask questions and provide feedback.  

Date: January 13, 2021

Format: ON-DEMAND

This meeting is for current members only. 

SPEAKERS: 

John O'Reardon, MD, CTMSS Annual Meeting Committee Co-chair
Dr. O’Reardon has been in practice as a psychiatrist for 30 years. He completed his residency training at Penn and Fellowships in Psychopharmacology & Cognitive Therapy (including training at the Beck Institute). In his clinical work as a faculty member at Penn he focused on treatment-resistant mood disorders and neuromodulation. This is the development of brain devices to stimulate the brain and treat mood disorders. These devices, which are increasing all the time, include transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), EEG-synchronized TMS (sTMS), deep TMS (dTMS) and transcranial direct current stimulation (tDCS).

Dr. O’Reardon was an active educator at Penn and over the years helped train more than a hundred psychiatry residents. He taught courses on neuromodulation, mood disorders and the History of Psychiatry. He has been a recipient of numerous teaching awards including the Earl Bond Award for excellence in teaching. He has been a frequent presenter at the annual meeting of the American Psychiatric Association (APA). Most recently he has presented a symposium on historical figures and mood disorders called Art, Politics and Creativity: Resilience in the Face of Great Odds – including Abraham Lincoln, Vincent Van Gogh, Winston Churchill and Sylvia Plath.

Dr. O’Reardon has been an active and productive researcher during his career. He has authored over a hundred publications in his career encompassing new brain devices (TMS, sTMS, VNS, DBS and tDCS), major depression, bipolar disorder, ECT and the night eating syndrome. He has been a lead investigator in many cutting edge clinical trials of new treatments for patients. He is first author on the primary trial that led to FDA approval for TMS as new exciting treatment for major depression. His current research work is with another exciting emerging treatment modality for major depression, namely tDCS.

Suzanne Kerns, MD, CTMSS Education Committee Co-chair
Dr. Suzanne Kerns is an Assistant Professor of Psychiatry in the Brain Stimulation Service at the Medical University of South Carolina. She serves as the Co-Chair of the Education Committee, alongside Dr. Michelle Cochran, and sits on the Board of Directors of the Clinical TMS Society.  Dr. Kerns is experienced in the use of a variety of neuromodulation techniques including ECT, TMS, DBS, and VNS. Her special interests include expanding the use of brain stimulation within Women's mental health, neuromodulation education, and holistic and integrative approaches to brain health.

Martha Koo, MD, CTMSS Research Committee Co-chair
Martha B Koo, M.D, has offered psychiatry and psychoanalysis in her private practice in Manhattan Beach, CA, since 1996. In 2009, she certified in Transcranial Magnetic Stimulation. She is the Founder of Neuro Wellness Spa, a mental health company with four locations that offers rTMS, IV ketamine, iV nutrition and photobiomodulation. Dr. Koo joined the CTMSS Board of Directors in 2020 and is co-chair of the Research Committee.

Mohamed Abdelghani, MBBCh, MSc, MRCPsych, CTMSS Outreach Committee Co-chair
Dr Mohamed Abdelghani is a consultant psychiatrist in London in the UK. He founded the first clinical TMS service in the NHS (public sector) in London and South England. He is actively involved in TMS clinical research and he is the London Principal Investigator for the BRIGhTMIND TMS Randomised Control Trial. In addition to the TMS service he runs in the NHS Dr Abdelghani also offers TMS through his private clinic.

Paul Croarkin, DO, CTMSS Clinical Standards Committee Co-chair
Dr. Croarkin’s research program focuses on adapting and innovating brain stimulation interventions in children and adolescents.  This includes biomarker work to optimize diagnostic practices and the delivery of brain based interventions such as transcranial magnetic stimulation.  A central theme focuses on the role of gamma-aminobutyric acid (GABA) and glutamate neurotransmitter systems in early-onset mood disorders with the goal of informing safer and more effective biologic treatments. Dr. Croarkin is a professor of psychiatry in the Mayo Clinic College of Medicine.

Rebecca Allen, MD, CTMSS Insurance Committee Co-chair
Dr. Allen has authored several papers and participated in research on sleep and memory consolidation, quality of life in multiple sclerosis, comparing TMS protocols and other projects. She authored a chapter on Sleep and Sleep Disorders for the Harvard textbook Neuropsychiatry and Behavioral Neurology: Principles and Practice (2020).  Her main clinical interest is neuropsychiatry: she is trained in the neurobiological bases and treatment of cognitive and behavioral manifestations of neurodegenerative diseases (dementia), multiple sclerosis, epilepsy, stroke, brain tumors, developmental disorders, traumatic brain injury and other disorders. Other clinical interests include electroconvulsive therapy, transcranial magnetic stimulation, and the interaction between sleep and psychiatric disorders. She has held local and national leadership positions, including serving on the Board of the Clinical TMS Society and as the President of the Washington State Psychiatric Association for 2020-21.

Ken Goolsby, MD, CTMSS Membership Committee Co-chair
Kenneth E. Goolsby, MD has been in private practice in Gainesville since 1987. As a child, adolescent and adult psychiatrist, he provides diagnostic evaluations, individual and family psychotherapy, medication evaluation and management, crisis intervention, and chemical dependency evaluations. Dr. Goolsby provides inpatient hospital care as well as outpatient care.

Dr. Goolsby earned his bachelor's degree at the University of Georgia and his medical degree at the Medical College of Georgia. He completed his psychiatric residency at the William S. Hall Psychiatric Institute Emory University. He then completed his child psychiatry fellowship at William S. Hall Psychiatric Institute. He is a diplomate of the American Board of Psychiatry and Neurology.

Ian Cook, MD, CTMSS Legal, Business, and Ethics Commitee Co-chair
Ian A. Cook, M.D. holds the Joanne and George Miller and Family Endowed Chair in Depression Research. He is a Professor of Psychiatry and Biobehavioral Sciences in the David Geffen School of Medicine, and a Research Scientist at the Semel Institute for Neuroscience and Human Behavior. Dr. Cook received his bachelors degree with high honors from Princeton University and his medical degree from the Yale University School of Medicine. He completed his psychiatry residency training at UCLA's Neuropsychiatric Institute, where he also was an NIMH-funded research fellow. Dr. Cook served on the Executive Committee on Practice Guidelines of the American Psychiatric Association, and guided the electronic dissemination of their evidence-based guidelines in psychiatry. A board-certified Psychiatrist, he has also served as an examiner for the American Board of Psychiatry and Neurology. His biography is profiled in Who's Who in America, Who's Who in the World, and Best Doctors. He is the author of numerous publications on brain function in mental illness and in aging, and holds several patents on biomedical devices and methods.

Michelle Cochran, MD, CTMSS Education Committee Co-chair, Practice Guidelines Committee Co-chair, ACROSS Representative to APA
Dr. Cochran currently works as the medical director of the Nashville Center for Hope & Healing and the NeuroScience and TMS treatment centers; in addition she maintains a role as a private practice psychiatrist.  Dr Cochran has experience treating a variety of psychiatric conditions, using a comprehensive approach with therapy, counseling, pharmacogenomic testing, medication, and neuromodulation. She received her undergraduate degree at Centre College, her medical training at University of Louisville School of Medicine, and she completed her postgraduate medical education at Vanderbilt University Medical Center in Nashville, Tennessee. During her psychiatry residency she was Chief Resident.  Additionally, she completed the Management Program for Physicians and Senior Healthcare Administrators at Vanderbilt University, Owen School of Management.  A current diplomat of the American Board of Psychiatry and Neurology (with active maintenance of certification), Dr. Cochran is a member of the Tennessee Psychiatric Association, Tennessee Medical Association, Nashville Academy of Medicine, Tennessee Women in Medicine, and Southern Psychiatric Association. Since her residency years, she has also been a member, Fellow (2011), and now Distinguished Fellow (2018) of the American Psychiatric Association. Dr. Cochran has been on the Clinical Faculty in the Department of Psychiatry at Vanderbilt University Medical Center since 1996 and has lectured to undergraduate, graduate, and postgraduate students as well as private practitioners.  For over 15 years, she has been active on numerous advisory boards professionally and personally.  Before retiring from inpatient psychiatric care and establishing her outpatient private practice, she was the medical director for many psychiatric units and programs in the Middle Tennessee area. Since 2011, Dr. Cochran has offered repetitive transcranial magnetic stimulation to her patients as an option for the treatment of Major Depressive Disorder.  Dr. Cochran and her staff have trained extensively in the use of repetitive transcranial Magnetic Stimulation (rTMS) including training at Berenson Allen’s Non-Invasive Brain Institute, Duke University and other specific advanced device trainings.  She has been active in the Clinical TMS Society (CTMSS) on many levels including serving on the executive committee as the VP-Elect (2016-2017), President (2017-2018), and with the Education and Annual meeting committees.  Most recently she has been helping advance the PULSES introductory course with other active CTMSS board members.

MODERATED BY: 

Randy Pardell, MD, CTMSS President Elect
Dr. Pardell is currently the Vice President/President-elect of the Clinical TMS Society.  He has served on the Board of Directors of CTMSS for the past 4 years and has been elected to the Executive Committee as Member at Large for two terms and now as Vice President. He has been past Chairman of the Outreach Committee and has served on the Membership and Education Committees. He has been a returning lecturer for the CTMSS Pulses Course.   He has been practicing TMS therapy since 2009. He co-wrote the first lay book on TMS called 3000 Pulses. Dr. Pardell is an honors graduate of the University of Pennsylvania and New York University School of Medicine. He completed his residency and chief residency at the St. Luke’s Roosevelt Medical Center and Post-Doctoral Fellowship at Columbia University where he performed smoking cessation research with Alexander Glassman MD. After graduation from his psychiatric training, Dr. Pardell moved up with his wife to the beautiful Hudson Valley, New York to start a practice and raise a family. Dr. Pardell is a Distinguished Life Fellow of the American Psychiatric Association and has been a past President of the Mid-Hudson Psychiatric Society and had been its Program Director for over a decade. Dr. Pardell founded Riverview Psychiatric Medicine, PC and TMS Center of the Hudson Valley and leads an active group psychiatric and TMS practice.